These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 9313638

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Guevara CA, Blain CR, Stahl D, Lythgoe DJ, Leigh PN, Barker GJ.
    Eur J Neurol; 2010 Sep; 17(9):1193-1202. PubMed ID: 20402762
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
    Federico F, Simone IL, Lucivero V, Mezzapesa DM, de Mari M, Lamberti P, Petruzzellis M, Ferrari E.
    Ital J Neurol Sci; 1999 Aug; 20(4):223-9. PubMed ID: 10551908
    [Abstract] [Full Text] [Related]

  • 7. A disease-specific metabolic brain network associated with corticobasal degeneration.
    Niethammer M, Tang CC, Feigin A, Allen PJ, Heinen L, Hellwig S, Amtage F, Hanspal E, Vonsattel JP, Poston KL, Meyer PT, Leenders KL, Eidelberg D.
    Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
    [Abstract] [Full Text] [Related]

  • 8. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA, Acosta-Cabronero J, Patterson K, Diaz-de-Grenu LZ, Williams GB, Nestor PJ.
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [Abstract] [Full Text] [Related]

  • 9. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ, Ofori E, Pasternak O, Burciu RG, Shukla P, DeSimone JC, Okun MS, McFarland NR, Vaillancourt DE.
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [Abstract] [Full Text] [Related]

  • 10. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
    Federico F, Simone IL, Lucivero V, Iliceto G, De Mari M, Giannini P, Mezzapesa DM, Tarantino A, Lamberti P.
    Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213
    [Abstract] [Full Text] [Related]

  • 11. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM, Carpenter K, Cartwright H, Halliday GM.
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [Abstract] [Full Text] [Related]

  • 12. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging.
    Tedeschi G, Bertolino A, Lundbom N, Bonavita S, Patronas NJ, Duyn JH, Metman LV, Chase TN, Di Chiro G.
    Neurology; 1996 Sep; 47(3):696-704. PubMed ID: 8797467
    [Abstract] [Full Text] [Related]

  • 13. Proton MR spectroscopic imaging of the striatum in Parkinson's disease.
    Cruz CJ, Aminoff MJ, Meyerhoff DJ, Graham SH, Weiner MW.
    Magn Reson Imaging; 1997 Sep; 15(6):619-24. PubMed ID: 9285801
    [Abstract] [Full Text] [Related]

  • 14. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
    Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, Barnett IS, Duyn JH, Frank JA, Rapoport JL, Weinberger DR.
    Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.
    Ellis CM, Lemmens G, Williams SC, Simmons A, Dawson J, Leigh PN, Chaudhuri KR.
    Neurology; 1997 Aug; 49(2):438-44. PubMed ID: 9270574
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, Weiner MW, Rosen HJ.
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [Abstract] [Full Text] [Related]

  • 19. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
    Hirano S, Shinotoh H, Shimada H, Aotsuka A, Tanaka N, Ota T, Sato K, Ito H, Kuwabara S, Fukushi K, Irie T, Suhara T.
    Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417
    [Abstract] [Full Text] [Related]

  • 20. [18F]-FDopa positron emission tomography imaging in corticobasal syndrome.
    El Ouartassi A, Giordana C, Schiazza A, Chardin D, Darcourt J.
    Brain Imaging Behav; 2023 Dec; 17(6):619-627. PubMed ID: 37474673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.